Profilo
Ron Newbold is currently the Director at the University of Virginia Licensing & Ventures Group, the Chief Business Officer at Empire Discovery Institute, Inc., and the President at Scottsdale Medical Imaging Ltd. Previously, he held positions such as Senior Director at Merck & Co., Inc., Chief Business Officer at Auspex Pharmaceuticals, Inc., Chief Business Officer at Spinogenix, Inc., Senior Vice President at Otsuka America Pharmaceutical, Inc., Senior Vice President at Celldex Therapeutics, Inc., Vice President at Pfizer Inc., and Executive Vice President at Sentigen Biosciences, Inc. Dr. Newbold obtained his undergraduate degree from Union College (New York) in 1984, his MBA from Columbia Business School in 2003, and his doctorate from Rochester Christian University in 1989.
Posizioni attive di Ron Newbold
| Società | Posizione | Inizio |
|---|---|---|
University of Virginia Licensing & Ventures Group
University of Virginia Licensing & Ventures Group Investment ManagersFinance UVA LVG invests in companies located in the United States. The firm focuses on companies operating in the fields of technology, health and educational sectors. It provides financing for seed and early stage capital requirements. | Direttore/Membro del Consiglio | - |
Empire Discovery Institute, Inc.
Empire Discovery Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides litigation support services | Corporate Officer/Principal | 01/03/2021 |
Scottsdale Medical Imaging Ltd.
Scottsdale Medical Imaging Ltd. Medical/Nursing ServicesHealth Services Provides medical imaging services | Presidente | - |
Precedenti posizioni note di Ron Newbold
| Società | Posizione | Fine |
|---|---|---|
Spinogenix, Inc.
Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops neurorestorative therapeutics | Corporate Officer/Principal | 01/03/2021 |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Investitore di Private Equity | 31/12/2019 |
| PFIZER INC. | Investitore di Private Equity | 30/11/2017 |
| AUSPEX PHARMACEUTICALS INC | Corporate Officer/Principal | 31/12/2010 |
| CELLDEX THERAPEUTICS, INC. | Investitore di Private Equity | 31/12/2009 |
Formazione di Ron Newbold
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Union College (New York)
Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Sentigen Biosciences, Inc. | |
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Scottsdale Medical Imaging Ltd.
Scottsdale Medical Imaging Ltd. Medical/Nursing ServicesHealth Services Provides medical imaging services | Health Services |
University of Virginia Licensing & Ventures Group
University of Virginia Licensing & Ventures Group Investment ManagersFinance UVA LVG invests in companies located in the United States. The firm focuses on companies operating in the fields of technology, health and educational sectors. It provides financing for seed and early stage capital requirements. | Finance |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spinogenix, Inc.
Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops neurorestorative therapeutics | Health Technology |
Empire Discovery Institute, Inc.
Empire Discovery Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides litigation support services | Commercial Services |
















